Cover Image

Ianyliu/fatty-liver-explainable-ai: First Version

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	Ian Liu
Format:	Recurso digital
Published:	Zenodo 2025
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

best ai ai tool for ai image generation
by: AiToolsList.xyz
Published: (2026)

Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
by: Yu‐Ming Cheng, et al.
Published: (2024)

best ai ai tool for image
by: AiToolsList.xyz
Published: (2026)

BioBricks.ai: A Versioned Data Registry for Life Sciences Data Assets
by: Gao, Yifan, et al.
Published: (2024)

best ai ai tool for user research tool
by: AiToolsList.xyz
Published: (2026)

Proximate and fatty acid composition of liver and fatty tissue of patin catfish (Pangasianodon hypophthalmus)
by: Shabani Kakroodi, S., et al.
Published: (2014)

The relationship between folic acid and nonalcoholic fatty liver disease
by: Bing'er Xu, et al.
Published: (2024)

Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
by: Xinyu Han, et al.
Published: (2024)

Editorial: Paradox of liver fat content in the spectrum of non‐alcoholic fatty liver disease
by: Sung Won Chung, et al.
Published: (2024)

Erythropoietin hyporesponsiveness in non‐alcoholic fatty liver disease
by: Huixi Zou, et al.
Published: (2024)

Emerging roles of RNA‐binding proteins in fatty liver disease
by: Oluwafolajimi Adesanya, et al.
Published: (2024)

Analytical methods for evaluation of the fatty acid metabolism in rat liver
by: Eduardo Hideo Gilglioni
Published: (2018)

Longitudinal changes in vibration‐controlled transient elastography in pediatric fatty liver disease
by: Katherine F. Sweeny, et al.
Published: (2026)

Prevalence and predictors of non‐alcoholic fatty liver disease (NAFLD) and metabolic dysfunction‐associated fatty liver disease (MAFLD) in Indian women with polycystic ovarian syndrome
by: Aditi Rathi, et al.
Published: (2025)

7‐Hydroxyflavone improves nonalcoholic fatty liver disease by acting on STK24
by: Xinyi Qi, et al.
Published: (2024)

Arte ai margini
Published: (2024)

Identification and validation of cuproptosis‐related molecular clusters in non‐alcoholic fatty liver disease
by: Changxu Liu, et al.
Published: (2024)

Letter to “Prevalence and predictors of non‐alcoholic fatty liver disease ( NAFLD ) and metabolic dysfunction‐associated fatty liver disease ( MAFLD ) in Indian women with polycystic ovarian syndrome”
by: Francis de Zegher, et al.
Published: (2025)

Impact of silymarin‐supplemented cookies on liver enzyme and inflammatory markers in non‐alcoholic fatty liver disease patients
by: Hafiza Madiha Jaffar, et al.
Published: (2024)

Metabolic fatty liver syndromes: where do we stand in 2024?
by: Wah‐Kheong Chan, et al.
Published: (2024)

Lipid sensing nuclear receptors involved in the pathogenesis of fatty liver disease
by: Marion Schweiger, et al.
Published: (2024)

Cardiac remodelling in non‐alcoholic fatty liver disease in the general population
by: Frederik Kostka, et al.
Published: (2024)

Dynamic pattern of postprandial bile acids in paediatric non‐alcoholic fatty liver disease
by: Jiating Huang, et al.
Published: (2024)

Functional roles of folic acid in alleviating dexamethasone‐induced fatty liver syndrome in laying hens
by: Xi Sun, et al.
Published: (2024)

Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease
by: Maria C. Rieman‐Klingler, et al.
Published: (2024)

Incorporation and fatty acid composition in liver of Nile tilapia fed with flaxseed oil
by: Polyana Batoqui França
Published: (2011)

LIVERSTAT for risk stratification for patients with metabolic dysfunction‐associated fatty liver disease
by: Yong Wen Leow, et al.
Published: (2024)

Farrerol alleviates insulin resistance and hepatic steatosis of metabolic associated fatty liver disease by targeting PTPN1
by: Jingwen Gao, et al.
Published: (2024)

Electrocardiogram-based diagnosis of liver diseases: an externally validated and explainable machine learning approach
by: Alcaraz, Juan Miguel Lopez, et al.
Published: (2024)

Sex differences in mortality and liver‐related events in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
by: Huimin Zhou, et al.
Published: (2024)

Validation of serum non‐invasive tests of liver fibrosis as prognostic markers of clinical outcomes in people with fatty liver disease in Australia
by: Karl Vaz, et al.
Published: (2024)

Defining ai applications in clinical routine
by: Leopold Schmetterer
Published: (2025)

Hepatoprotective effects and mechanisms of l‐theanine and epigallocatechin gallate combined intervention in alcoholic fatty liver rats
by: Kai‐Hang Xu, et al.
Published: (2024)

Helicobacter pylori and metabolic syndrome‐related adipokines in nonalcoholic fatty liver disease pathophysiology
by: J Kountouras, et al.
Published: (2024)

Regulation of UCP2 in nonalcoholic fatty liver disease: From mechanisms to natural product
by: Liyuan Hao, et al.
Published: (2024)

Frequency of non-alcoholic fatty liver disease in a series of forensic cases in Mexico
by: Rafael Rojano-Ramón
Published: (2021)

Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease? A systematic review, meta‐analysis, and meta‐regression
by: Jerónimo Aragón‐Vela, et al.
Published: (2024)

Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures
by: Xiong Pei, et al.
Published: (2024)

Gut microbiota dysbiosis links chronic apical periodontitis to liver fibrosis in nonalcoholic fatty liver disease: Insights from a mouse model
by: Guowu Gan, et al.
Published: (2024)

Association of metabolic dysfunction‐associated fatty liver disease with gallstone development: A longitudinal study
by: Masahiro Sogabe, et al.
Published: (2024)